Large German cohort finds data-driven evidence gut bacteria contribute to depression

A study published 21 August in the journal Gut Microbes reports data-driven evidence that specific gut bacteria contribute causally to major depressive disorder in humans — a claim animal studies have supported for years but that has been difficult to establish in people [s1]. The peer-reviewed paper is the final version of work first posted as a preprint in December 2024 [s2]; the research was led by Dominik Heider at the University of Münster together with collaborators across several German and international institutions, including University Medical Centre Frankfurt, Christian-Albrechts-University Kiel, and RWTH Aachen [s1].

Depression is one of the leading causes of disability worldwide, and interest in the gut-brain connection has grown quickly. But most of the human evidence to date has come from small, cross-sectional studies that can show gut bacteria and depression are correlated without being able to say which, if either, is causing the other [s2].

What the researchers did

The team drew on one of the largest multicenter cohorts available with both microbiome data and detailed psychiatric diagnostic assessment: 1,269 people, a mix of individuals diagnosed with major depressive disorder and healthy controls, from the German FOR2107 research consortium [s2].

Their approach had two stages. First, they compared the relative abundance of gut bacteria between people with depression and controls, to replicate what smaller prior studies had found. Second — the methodologically novel part — they applied what the paper describes as "state-of-the-art, fully data-driven causal inference tools" built on Judea Pearl's framework for causal reasoning, designed to derive constraints about cause and effect directly from the data rather than assuming them in advance, as earlier approaches have had to do [s2].

What they found

In the replication stage, the researchers found a significant difference between people with depression and healthy controls in the relative abundance of four bacterial groups: Eggerthella, Hungatella, Coprobacillus, and Lachnospiraceae FCS020 [s2].

Applying the causal-inference framework to that data, two of those four — Eggerthella and Hungatella — showed evidence of being causal contributors to depression, rather than simply markers that happen to travel alongside it [s2]. The two bacteria appeared to work through distinct pathways: their association with depression held even after accounting for body mass index, suggesting the link isn't simply an artifact of obesity's known association with both altered gut bacteria and depression [s2]. The difference in abundance between the two groups also held regardless of whether patients were taking antidepressant medication [s2].

The authors describe this as "the first evidence for a potential causal role of gut-microbiota in the pathophysiology of depression in humans" [s2].

What "causal" means here, and its limits

It's worth being precise about what kind of evidence this is. The study is not a randomized trial — nobody's gut bacteria were experimentally manipulated and then monitored for depression. It is an observational cohort analyzed with causal-inference statistical methods designed to distinguish plausible causal relationships from mere correlation, using the structure of the data itself rather than an experiment. That's a meaningfully stronger form of evidence than a simple correlation, but it remains inference from observational data, not a controlled experiment — the gold standard for causal claims. The paper's own framing, "data-driven evidence suggests," reflects that caveat.

The study also can't say what these bacteria are doing mechanistically — whether it's inflammatory signaling, metabolite production, effects on the vagus nerve, or something else entirely — or whether increasing or decreasing their abundance in a person would change depression symptoms. And FOR2107 is a German cohort; whether the same bacterial associations hold in other populations with different diets, genetics, and healthcare contexts is untested here.

What it means for readers

This is not evidence that a probiotic, dietary change, or supplement targeting these bacteria treats or prevents depression — no such intervention was tested. What it adds is a stronger piece of human evidence, using a large and well-characterized cohort, for a research direction that has mostly relied on animal models and smaller, weaker human studies. It moves the gut-microbiome-depression hypothesis further from speculative and closer to testable.

What to watch next

Whether Eggerthella and Hungatella replicate as causal candidates in independent cohorts, and whether any interventional trial — testing a probiotic, dietary intervention, or other approach designed to shift these specific bacterial populations — is designed to test the hypothesis this study generates.

This article is informational and is not medical advice.

Sources

1. From gut to brain: data-driven evidence suggests causal contribution of gut-microbiota to major depressive disorder in humans — Gut Microbes, 21 August 2026
2. From Gut to Brain: Evidence for a Causal Contribution of Gut-Microbiota to Major Depressive Disorder in Humans (preprint) — medRxiv, 6 December 2024